European female founders didn’t let up in November, pulling in fresh capital after October’s strong showing as investors bet on AI tools, personalised meds and battery recycling tech.
Among the early-stage highlights, UK solo founder Phoebe Gormley landed a £3 million pre-seed for Fit Collective, her AI fashion sizing platform that’s already cutting returns by 30% in pilots with brands. Midlands healthtech Rem3dy Health scooped £1.4 million from Borski Fund and Future Planet Capital to scale its 3D-printed personalised pills that mix multiple drugs into one dose. Germany’s dotega, meanwhile, grabbed €1.3 million in pre-seed to digitise management for small homeowners’ associations.
Meanwhile, Adaptronics raised €3.15 million for electrostatic grippers that could make industrial robots far more dexterous and cheap to deploy across factories. Euler, building AI to spot defects in 3D prints, closed a €2 million seed round. And Einride’s $1.8 billion SPAC prep, with deputy CEO Linnéa Kornehed shining.
The Lithuania-based company, founded in 2008 by Milda Mitkutė and Justas Janauskas, built Europe’s largest resale platform by charging fees to buyers rather than sellers. It now has 100 million users across 22 countries, with the strongest growth in France and Germany.
Vinted achieved profitability this year on €10 billion in gross merchandise value, up from €813 million in revenue in 2024. Backers, including Accel, Lightspeed Venture Partners and Insight Partners, stand to benefit from the potential sale
In November, Vinted eyed a secondary share sale that could value the second-hand fashion marketplace at €8 billion. The round would provide liquidity to early investors and employees as the company reports 2025 revenue exceeding €1 billion.
Founders: Sebastian Gabor, Ruxandra Pui
Founded: 2017
Total funding: $36.9M
Founded in 2018 in Iași by Sebastian Gabor and Ruxandra Pui, Digitail offers an all-in-one cloud platform covering scheduling, records, invoicing, inventory, client chat, telemedicine and a pet owner app. Its AI features include automated SOAP note dictation and patient intake and summaries via agents like Tails Concierge and Tails Medical.
The company now serves 10,000 veterinarians and 3 million pet owners, doubling its customer base in the past year across independent clinics and multi-location groups with 30+ integrations. It stands out from rivals like Covetrus and Provet Cloud by building AI natively from day one.
In November 2025, Digitail closed a $23 million Series B round led by Five Elms Capital, bringing its total funding to over $37 million as it pushes AI tools to cut admin work in veterinary clinics.
The app offers IBAN accounts, debit cards, crypto exchanges, DeFi yield via Vaults, and full user control over private keys with recovery features. Regulated as an Electronic Money Institution by ACPR (Banque de France) and holding France’s first MiCA license from AMF, Deblock has gained over 300,000 users since its April 2024 France launch. It now plans to expand into Europe, starting with Germany and Ireland in 2026.
In November 2025, Deblock secured €30 million in Series A funding led by Speedinvest, with participation from CommerzVentures and Latitude, to grow its platform that combines euro current accounts with self-custody crypto wallets. The funding supports product localisation, German customer support, and enhancements to on-chain banking.
Founders: Werner Schmidt and Laura Tortosa Sancho
Founded: 2022
Total funding: $10.1M
Founded in 2022 by Werner Schmidt and Laura Tortosa Sancho, Lative automates sales planning by connecting top-down quotas with bottom-up productivity data from CRM, HR and finance systems. Customers like Seismic, Intercom, Aiven, Avalara and Version 1 report up to 24% productivity gains and can deploy in 30 minutes.
The cloud platform offers AI insights for capacity modelling, quota simulation, risk detection, and execution tracking, integrating with Salesforce, HubSpot, and Snowflake (150+ sources in total). It ranks #2 on G2’s Sales Planning Grid behind Salesforce. Lative grew 10x in 15 months amid a $2.3 billion market projected to hit $7 billion by 2030.
Founded in 2020 by Jenny Button, Emm developed a medical-grade silicone menstrual cup with integrated sensors that automatically track flow volume, duration and cycle patterns without manual logging. Data syncs via a charging case to an app providing insights on daily rates, total volume and predictions after three cycles
The 12-hour capacity device aims to improve menstrual health monitoring and detect issues such as endometriosis. Emm has a 30,000-person waitlist and plans clinical development for broader reproductive health applications.
In November 2025, Emm has raised $9 million in an oversubscribed seed round led by Lunar Ventures, with participation from Labcorp Venture Fund, Tiny VC, BlueLion Global, Alumni Ventures and angels including Amar Shah and Vivek Garipalli.
The funding will support a 2026 U.K. launch and a 2027 U.S. entry.
The platform manages billing, pauses, swaps, inventory and churn across 500,000+ active subscriptions for clients including Pulse4all, Mother’s Earth, Meowbox and Boerschappen. Early traction centres in the Netherlands, with plans for AI-native commerce features such as Model Context Protocol integrations.
In November 2025, Juo raised €4 million in seed funding led by Market One Capital and Peak, with participation from SMOK Ventures, BADideas, FJ Labs and Lakestar. The round brings total funding to around €5 million and will expand its platform for developers, operations teams and AI agents.
Founders: Lilian Walther Jallow, Cecilia Götherström
Founded: 2020
Total funding: $1.8M
BOOST Pharma, founded in 2020, develops allogeneic mesenchymal stem cells to treat infants with severe OI Type III/IV, aiming to reduce fractures and improve bone formation. Phase 2 (BOOSTB4) showed 75% fracture reduction and good safety.
The Stockholm-based company now prepares for Phase 3 trials. Karolinska Development CEO Viktor Drvota called it “transformative” for children with frequent fractures and deformities. Sound Bioventures joins BOOST Pharma as its financial position strengthens amid a rare-disease focus.
In November 2025, BOOST Pharma secured €3.1 million in a directed share issue from Sound Bioventures to advance its stem cell therapy BT-101 for osteogenesis imperfecta (OI), or brittle bone disease.
Founders: Arelys Sosa and Thomas Tingelöf
Founded: 2023
Total funding: $3.9M
Founded in 2023 in Gothenburg by CEO Arelys Sosa and CTO Thomas Tingelöf, DREV targets “black dust,” known as fine particles of lithium, nickel, cobalt and copper generated during electrode manufacturing. Its patented dry-brush Vault Mobile and Stationary units capture dust at source without water or chemicals, improving air quality, reducing slip risks and enabling metal recovery for reuse.
Gigafactory pilots (including those with Verkor in France) showed cleaner facilities and material recovery previously landfilled. With the EU Battery Regulation tightening waste rules, DREV helps manufacturers comply while cutting costs.
In November 2025, DREV closed a €2.8 million seed round co-led by Butterfly Ventures and Almi Invest Greentech, with participation from S-E-Bankens Utvecklingsstiftelse and U.S. fund Battle Born Venture. The funding will scale its Vault systems for capturing hazardous metal dust in battery production.
Founders: Karlee Ozener and Omer Ozener
Founded: 2020
Total funding: N/A
Founded in 2020 by Karlee Ozener and CEO Omer Ozener with £75,000 in personal savings, Hello Klean sells high-flow shower filters that remove chlorine, heavy metals and hard water minerals (calcium, magnesium), causing skin dryness and hair damage. Cartridges last 3-4 months and pair with complementary wash-off products; 70%+ revenue comes from subscriptions with 97% monthly retention.
Retailers include Selfridges, Cult Beauty, Sephora UK, Harvey Nichols and Ounass (GCC). A BBC Dragons’ Den feature drove 700% growth in orders, expanding the team from founders to 20 people (targeting 30). Cohorts break even in six months, profitable by eight
In November 2025, Hello Klean secured £1.5 million in debt financing from re:cap to scale inventory, enter new European and Middle East markets, and advance filtration technology after selling over 1 million units while staying profitable and founder-owned.
Read more on Tech Funding News
